{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T03:45:17Z","timestamp":1769053517238,"version":"3.49.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T00:00:00Z","timestamp":1747526400000},"content-version":"am","delay-in-days":290,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P30 DA029926"],"award-info":[{"award-number":["P30 DA029926"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32 DA037202"],"award-info":[{"award-number":["T32 DA037202"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.josat.2024.209383","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T06:31:39Z","timestamp":1713940299000},"page":"209383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evaluating preferences for medication formulation and treatment model among people who use opioids non-medically: A web-based cross-sectional study"],"prefix":"10.1016","volume":"163","author":[{"given":"Elizabeth C.","family":"Saunders","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan J.","family":"Budney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Cavazos-Rehg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Marsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.josat.2024.209383_bb0005","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/1475-6773.13113","article-title":"County-level access to opioid use disorder medications in medicare part D (2010-2015)","volume":"54","author":"Abraham","year":"2019","journal-title":"Health Services Research"},{"key":"10.1016\/j.josat.2024.209383_bb0010","series-title":"Integration of mental health\/substance abuse and primary care: Evidence report\/techology","volume":"173","author":"Agency for Healthcare Research and Quality (AHRQ)","year":"2008"},{"issue":"2","key":"10.1016\/j.josat.2024.209383_bb0015","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s12325-016-0472-9","article-title":"Pharmacokinetic evaluation of once-weekly and once-monthly buprenorphine subcutaneous injection depots (CAM2038) versus intravenous and sublingual buprenorphine in healthy volunteers under naltrexone blockade: An open-label phase 1 study","volume":"34","author":"Albayaty","year":"2017","journal-title":"Advances in Therapy"},{"key":"10.1016\/j.josat.2024.209383_bb0020","article-title":"Underutilization of medications to treat opioid use disorder: What role does stigma play?","volume":"1-7","author":"Allen","year":"2019","journal-title":"Substance Abuse"},{"issue":"1","key":"10.1016\/j.josat.2024.209383_bb0025","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s11606-019-05309-8","article-title":"The Tuskegee study of untreated syphilis: A case study in peripheral trauma with implications for health professionals","volume":"35","author":"Alsan","year":"2020","journal-title":"Journal of General Internal Medicine"},{"issue":"1","key":"10.1016\/j.josat.2024.209383_bb0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12888-018-1701-3","article-title":"Evaluation of an electronic consultation service in psychiatry for primary care providers","volume":"18","author":"Archibald","year":"2018","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1016\/j.josat.2024.209383_bb0035","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jsat.2013.04.002","article-title":"Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification","volume":"45","author":"Bailey","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2024.209383_bb0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1370\/afm.2632","article-title":"Discrimination and medical mistrust in a racially and ethnically diverse sample of California adults","volume":"19","author":"Bazargan","year":"2021","journal-title":"Annals of Family Medicine"},{"key":"10.1016\/j.josat.2024.209383_bb0045","article-title":"Opportunities for research on the treatment of substance use disorders in the context of COVID-19","author":"Blanco","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"10182","key":"10.1016\/j.josat.2024.209383_bb0050","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(18)33078-2","article-title":"Management of opioid use disorder in the USA: Present status and future directions","volume":"393","author":"Blanco","year":"2019","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.josat.2024.209383_bb0055","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugalcdep.2009.06.016","article-title":"Exploring the role of consumer participation in drug treatment","volume":"105","author":"Brener","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.josat.2024.209383_bb0060","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ADM.0000000000000310","article-title":"Vermont hub-and-spoke model of care for opioid use disorder: Development, implementation, and impact","volume":"11","author":"Brooklyn","year":"2017","journal-title":"Journal of Addiction Medicine"},{"issue":"6","key":"10.1016\/j.josat.2024.209383_bb0065","doi-asserted-by":"crossref","first-page":"813","DOI":"10.15288\/jsad.2018.79.813","article-title":"Web-based research: Strengths, weaknesses, and JSAD\u2019s guidance for authors","volume":"79","author":"Caetano","year":"2018","journal-title":"Journal of Studies on Alcohol and Drugs"},{"issue":"9","key":"10.1016\/j.josat.2024.209383_bb0070","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1176\/appi.ps.52.9.1230","article-title":"Patient satisfaction, use of services, and one-year outcomes in publicly funded substance abuse treatment","volume":"52","author":"Carlson","year":"2001","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.josat.2024.209383_bb0075","author":"Centers for Disease Control and Prevention (CDC)"},{"issue":"2","key":"10.1016\/j.josat.2024.209383_bb0080","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/ADM.0000000000000457","article-title":"Buprenorphine pharmacology review: Update on transmucosal and long-acting formulations","volume":"13","author":"Coe","year":"2019","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1016\/j.josat.2024.209383_bb0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1023\/A:1023254226592","article-title":"Pretesting survey instruments: An overview of cognitive methods","volume":"12","author":"Collins","year":"2003","journal-title":"Quality of Life Research"},{"issue":"1","key":"10.1016\/j.josat.2024.209383_bb0090","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-soc-060116-053613","article-title":"New developments in survey data collection","volume":"43","author":"Couper","year":"2017","journal-title":"Annual Review of Sociology"},{"issue":"4","key":"10.1016\/j.josat.2024.209383_bb0095","doi-asserted-by":"crossref","first-page":"298","DOI":"10.7326\/M15-0510","article-title":"The integration of care for mental health, substance abuse, and other behavioral health conditions into primary care: Executive summary of an American College of Physicians position paper","volume":"163","author":"Crowley","year":"2015","journal-title":"Annals of Internal Medicine"},{"issue":"10208","key":"10.1016\/j.josat.2024.209383_bb0100","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","article-title":"Global patterns of opioid use and dependence: Harms to populations, interventions, and future action","volume":"394","author":"Degenhardt","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.josat.2024.209383_bb0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/apc.2013.0179","article-title":"Patient perspectives of an integrated program of medical care and substance use treatment","volume":"28","author":"Drainoni","year":"2014","journal-title":"AIDS Patient Care and STDs"},{"issue":"Suppl. 1","key":"10.1016\/j.josat.2024.209383_bb0110","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1097\/QAI.0b013e3182097561","article-title":"Patient perspectives on buprenorphine\/naloxone treatment in the context of HIV care","volume":"56","author":"Egan","year":"2011","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.josat.2024.209383_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fsoc.2020.593925","article-title":"Breaching trust: A qualitative study of healthcare experiences of people who use drugs in a rural setting","volume":"5","author":"Ellis","year":"2020","journal-title":"Frontiers in Sociology"},{"key":"10.1016\/j.josat.2024.209383_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108589","article-title":"The intersection of race and opioid use disorder treatment: A quantitative analysis","volume":"131","author":"Entress","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209383_bb0125","series-title":"Drug user involvement in treatment decisions","author":"Fischer","year":"2007"},{"issue":"1","key":"10.1016\/j.josat.2024.209383_bb0130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jsat.2014.07.015","article-title":"Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participants","volume":"48","author":"Fox","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.josat.2024.209383_bb0135","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1176\/appi.ajp.2021.21040381","article-title":"Surging racial disparities in the U.S. overdose crisis","volume":"179","author":"Friedman","year":"2022","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2024.209383_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145817","article-title":"Patient preferences and shared decision making in the treatment of substance use disorders: A systematic review of the literature","volume":"11","author":"Friedrichs","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.josat.2024.209383_bb0145","doi-asserted-by":"crossref","DOI":"10.1111\/add.14636","article-title":"Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult outpatients with opioid use disorder","author":"Frost","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2024.209383_bb0150","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2147\/PPA.S180641","article-title":"Current and future options for opioid use disorder: A survey assessing real-world opinion of service users on novel therapies including depot formulations of buprenorphine","volume":"12","author":"Gilman","year":"2018","journal-title":"Patient Preference and Adherence"},{"key":"10.1016\/j.josat.2024.209383_bb0155","article-title":"Out damn bot, out: Recruiting real people into substance use studies on the internet","volume":"1-3","author":"Godinho","year":"2019","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2024.209383_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108551","article-title":"Experiences of racial discrimination in the medical setting and associations with medical mistrust and expectations of care among black patients seeking addiction treatment","volume":"133","author":"Hall","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"9","key":"10.1016\/j.josat.2024.209383_bb0165","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/MLR.0b013e3181792562","article-title":"Perceived discrimination in health care and health status in a racially diverse sample","volume":"46","author":"Hausmann","year":"2008","journal-title":"Medical Care"},{"key":"10.1016\/j.josat.2024.209383_bb0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1478-4505-10-37","article-title":"Reporting of feasibility factors in publications on integrated treatment programs for women with substance abuse issues and their children: A systematic review and analysis","volume":"10","author":"Henderson","year":"2012","journal-title":"Health Res Policy Syst"},{"issue":"11","key":"10.1016\/j.josat.2024.209383_bb0175","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1377\/hlthaff.2013.0541","article-title":"Mental health and addiction workforce development: Federal leadership is needed to address the growing crisis","volume":"32","author":"Hoge","year":"2013","journal-title":"Health Affairs"},{"key":"10.1016\/j.josat.2024.209383_bb0180","article-title":"Integration of buprenorphine treatment with primary care: Comparative effectiveness on retention, utilization, and cost","author":"Hsu","year":"2018","journal-title":"Population Health Management"},{"issue":"7","key":"10.1016\/j.josat.2024.209383_bb0185","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/add.14180","article-title":"Extended-release injectable naltrexone for opioid use disorder: A systematic review","volume":"113","author":"Jarvis","year":"2018","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.josat.2024.209383_bb0190","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1037\/prj0000138","article-title":"How are perceived stigma, self-stigma, and self-reliance related to treatment-seeking? A three-path model","volume":"38","author":"Jennings","year":"2015","journal-title":"Psychiatric Rehabilitation Journal"},{"issue":"5","key":"10.1016\/j.josat.2024.209383_bb0195","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2024.209383_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108690","article-title":"Treatment preference for opioid use disorder among people who are incarcerated","volume":"137","author":"Kaplowitz","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2024.209383_bb0205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-statistics-031017-100127","article-title":"Web-based enrollment and other types of self-selection in surveys and studies: Consequences for generalizability","volume":"5","author":"Keiding","year":"2018","journal-title":"Annual Review of Statistics and Its Application"},{"issue":"3","key":"10.1016\/j.josat.2024.209383_bb0210","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/00952991003736371","article-title":"The role of patient satisfaction in methadone treatment","volume":"36","author":"Kelly","year":"2010","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2024.209383_bb0215","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jsat.2018.08.011","article-title":"Buprenorphine treatment formulations: Preferences among persons in opioid withdrawal management","volume":"94","author":"Kenney","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2024.209383_bb0220","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/08897077.2015.1129388","article-title":"Project ECHO (extension for community healthcare outcomes): A new model for educating primary care providers about treatment of substance use disorders","volume":"37","author":"Komaromy","year":"2016","journal-title":"Substance Abuse"},{"issue":"5","key":"10.1016\/j.josat.2024.209383_bb0225","first-page":"e194","article-title":"Opioid use disorder in primary care: PEER umbrella systematic review of systematic reviews","volume":"65","author":"Korownyk","year":"2019","journal-title":"Canadian Family Physician"},{"issue":"4","key":"10.1016\/j.josat.2024.209383_bb0230","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/ADM.0b013e3181cc9610","article-title":"Patients\u2019 reasons for choosing office-based buprenorphine: Preference for patient-centered care","volume":"4","author":"Korthuis","year":"2010","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2024.209383_bb0235","article-title":"Primary care-based models for the treatment of opioid use disorder: A scoping review","author":"Korthuis","year":"2016","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/j.josat.2024.209383_bb0240","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/mpr.1415","article-title":"Strategies to address participant misrepresentation for eligibility in web-based research","volume":"23","author":"Kramer","year":"2014","journal-title":"International Journal of Methods in Psychiatric Research"},{"issue":"10","key":"10.1016\/j.josat.2024.209383_bb0245","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax9140","article-title":"Current status of opioid addiction treatment and related preclinical research","volume":"5","author":"Kreek","year":"2019","journal-title":"Science Advances"},{"issue":"3","key":"10.1016\/j.josat.2024.209383_bb0250","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/YCO.0b013e3283386578","article-title":"Long-acting depot formulations of naltrexone for heroin dependence: A review","volume":"23","author":"Krupitsky","year":"2010","journal-title":"Current Opinion in Psychiatry"},{"issue":"10","key":"10.1016\/j.josat.2024.209383_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186315","article-title":"Primary care models for treating opioid use disorders: What actually works? A systematic review","volume":"12","author":"Lagisetty","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.josat.2024.209383_bb0260","article-title":"Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia","author":"Larance","year":"2019","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.josat.2024.209383_bb0265","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.23032","article-title":"Comparison of treatment retention of adults with opioid addiction managed with extended-release buprenorphine vs daily sublingual buprenorphine-naloxone at time of release from jail","volume":"4","author":"Lee","year":"2021","journal-title":"JAMA Network Open"},{"issue":"14","key":"10.1016\/j.josat.2024.209383_bb0270","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1001\/jama.2010.1427","article-title":"Buprenorphine implants for treatment of opioid dependence: A randomized controlled trial","volume":"304","author":"Ling","year":"2010","journal-title":"The Journal of the American Medical Association"},{"key":"10.1016\/j.josat.2024.209383_bb0275","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/SAR.S155843","article-title":"Depot buprenorphine injection in the management of opioid use disorder: From development to implementation","volume":"10","author":"Ling","year":"2019","journal-title":"Substance Abuse and Rehabilitation"},{"issue":"17","key":"10.1016\/j.josat.2024.209383_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12175575","article-title":"Long-acting buprenorphine formulations as a new strategy for the treatment of opioid use disorder","volume":"12","author":"Maremmani","year":"2023","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.josat.2024.209383_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102311","article-title":"Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: A pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial","volume":"66","author":"Marsden","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"10","key":"10.1016\/j.josat.2024.209383_bb0290","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022267","article-title":"Patient engagement, treatment preferences and shared decision-making in the treatment of opioid use disorder in adults: A scoping review protocol","volume":"8","author":"Marshall","year":"2018","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.josat.2024.209383_bb0295","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.3821","article-title":"Use of medication for opioid use disorder among US adolescents and adults with need for opioid treatment, 2019","volume":"5","author":"Mauro","year":"2022","journal-title":"JAMA Network Open"},{"issue":"10","key":"10.1016\/j.josat.2024.209383_bb0300","doi-asserted-by":"crossref","first-page":"690","DOI":"10.7326\/M16-0317","article-title":"Performance of the tobacco, alcohol, prescription medication, and other substance use (TAPS) tool for substance use screening in primary care patients","volume":"165","author":"McNeely","year":"2016","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1016\/j.josat.2024.209383_bb0305","first-page":"327","article-title":"Mutual mistrust in the medical care of drug users: The keys to the \u201cnarc\u201d cabinet","volume":"17","author":"Merrill","year":"2002","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.josat.2024.209383_bb0310","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","article-title":"Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population","volume":"85","author":"Morgan","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209383_bb0315","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jsat.2019.01.019","article-title":"Using nominal group technique to identify barriers, facilitators, and preferences among patients seeking treatment for opioid use disorder: A needs assessment for decision making support","volume":"100","author":"Muthulingam","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209383_bb0320","series-title":"Provisional drug overdose death counts","volume":"November 16, 2022","author":"National Center for Health Statistics","year":"2022"},{"key":"10.1016\/j.josat.2024.209383_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2018.03.057","article-title":"Implants and depot injections for treating opioid dependence: Qualitative study of people who use or have used heroin","volume":"189","author":"Neale","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.josat.2024.209383_bb0330","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1037\/pha0000217","article-title":"Patient views of opioid pharmacotherapy biodelivery systems: Qualitative study to assist treatment decision making","volume":"26","author":"Neale","year":"2018","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"1","key":"10.1016\/j.josat.2024.209383_bb0335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12954-019-0296-4","article-title":"Prolonged-release opioid agonist therapy: Qualitative study exploring patients\u2019 views of 1-week, 1-month, and 6-month buprenorphine formulations","volume":"16","author":"Neale","year":"2019","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2024.209383_bb0340","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsat.2016.07.003","article-title":"HIV patients\u2019 preference for integrated models of addiction and HIV treatment in Vietnam","volume":"69","author":"Nguyen Bich","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.josat.2024.209383_bb0345","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.chiabu.2011.10.007","article-title":"Integrated programs for mothers with substance abuse issues and their children: A systematic review of studies reporting on child outcomes","volume":"36","author":"Niccols","year":"2012","journal-title":"Child Abuse and Neglect"},{"issue":"1","key":"10.1016\/j.josat.2024.209383_bb0350","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13104-021-05601-z","article-title":"Opioid use, motivation to quit, and treatment status related to COVID-19: A cross-sectional study","volume":"14","author":"Parker","year":"2021","journal-title":"BMC Research Notes"},{"key":"10.1016\/j.josat.2024.209383_bb0355","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jsat.2019.06.010","article-title":"A comparison of buprenorphine and psychosocial treatment outcomes in psychosocial and medical settings","volume":"104","author":"Presnall","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"7","key":"10.1016\/j.josat.2024.209383_bb0360","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3109\/10826084.2014.891615","article-title":"Barriers to substance abuse treatment in rural and urban communities: Counselor perspectives","volume":"49","author":"Pullen","year":"2014","journal-title":"Substance Use and Misuse"},{"issue":"3","key":"10.1016\/j.josat.2024.209383_bb0365","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s40596-015-0314-0","article-title":"The time is now: Improving substance abuse training in medical schools","volume":"40","author":"Ram","year":"2016","journal-title":"Academic Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2024.209383_bb0370","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11920-019-0985-4","article-title":"Evolving models of integrated behavioral health and primary care","volume":"21","author":"Ramanuj","year":"2019","journal-title":"Current Psychiatry Reports"},{"issue":"11","key":"10.1016\/j.josat.2024.209383_bb0375","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1176\/appi.ps.201900163","article-title":"Use of drug treatment services among adults with opioid use disorder: Rates, patterns, and correlates","volume":"70","author":"Rhee","year":"2019","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.josat.2024.209383_bb0380","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.addbeh.2018.03.012","article-title":"Correlates of specialty substance use treatment among adults with opioid use disorders","volume":"86","author":"Romo","year":"2018","journal-title":"Addictive Behaviors"},{"issue":"3","key":"10.1016\/j.josat.2024.209383_bb0385","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/jama.2016.9382","article-title":"Effect of buprenorphine implants on illicit opioid use among abstinent adults with opioid dependence treated with sublingual buprenorphine: A randomized clinical trial","volume":"316","author":"Rosenthal","year":"2016","journal-title":"Journal of the American Medical Association"},{"issue":"4","key":"10.1016\/j.josat.2024.209383_bb0390","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4103\/psychiatry.IndianJPsychiatry_211_18","article-title":"Innovative telementoring for addiction management for remote primary care physicians: A feasibility study","volume":"60","author":"Sagi","year":"2018","journal-title":"Indian Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2024.209383_bb0395","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13722-021-00213-1","article-title":"\u201cIt\u2019s way more than just writing a prescription\u201d: A qualitative study of preferences for integrated versus non-integrated treatment models among individuals with opioid use disorder","volume":"16","author":"Saunders","year":"2021","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2024.209383_bb0400","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jsat.2020.01.009","article-title":"Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders","volume":"111","author":"Saunders","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2024.209383_bb0410","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13011-017-0104-7","article-title":"Strategies to facilitate integrated care for people with alcohol and other drug problems: A systematic review","volume":"12","author":"Savic","year":"2017","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"4","key":"10.1016\/j.josat.2024.209383_bb0415","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJMra1604339","article-title":"Treatment of opioid use disorders","volume":"375","author":"Schuckit","year":"2016","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.josat.2024.209383_bb0420","series-title":"Stata statistical software: Release 14","author":"StataCorp.","year":"2015"},{"key":"10.1016\/j.josat.2024.209383_bb0425","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jsat.2015.07.002","article-title":"Preferences for aftercare among persons seeking short-term opioid detoxification","volume":"59","author":"Stein","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209383_bb0430","doi-asserted-by":"crossref","DOI":"10.1080\/08897077.2017.1353570","article-title":"Overdose history is associated with post-detoxification treatment preference for persons with opioid use disorder","author":"Stein","year":"2017","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2024.209383_bb0435","series-title":"Paper presented at the American Association for the Treatment of Opioid Dependence (AATOD), Baltimore, MD","article-title":"Integrated service delivery models for opioid treatment programs in an era of increasing opioid addiction, health reform, and parity","author":"Stoller","year":"2016"},{"key":"10.1016\/j.josat.2024.209383_bb0440","series-title":"Health measurement scales: A practical guide to their development and use","author":"Streiner","year":"2015"},{"issue":"1","key":"10.1016\/j.josat.2024.209383_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/pha0000235","article-title":"The use of crowdsourcing in addiction science research: Amazon mechanical Turk","volume":"27","author":"Strickland","year":"2019","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.josat.2024.209383_bb0450","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)"},{"key":"10.1016\/j.josat.2024.209383_bb0455","series-title":"SAMHSA\/CSAT treatment improvement protocols. In medications for opioid use disorder: For healthcare and addiction professionals, policymakers, patients, and families","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2018"},{"key":"10.1016\/j.josat.2024.209383_bb0460","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsat.2018.04.008","article-title":"Integrated treatment programs for pregnant and parenting women with problematic substance use: Service descriptions and client perceptions of care","volume":"90","author":"Tarasoff","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"12","key":"10.1016\/j.josat.2024.209383_bb0465","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s11606-017-4140-9","article-title":"Partnering with psychiatry to close the education gap: An approach to the addiction epidemic","volume":"32","author":"Tetrault","year":"2017","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.josat.2024.209383_bb0470","series-title":"Tital pharmaceuticals provides a strategic and corporate update","volume":"October 15, 2020","author":"Titan Pharmaceuticals, I","year":"2020"},{"key":"10.1016\/j.josat.2024.209383_bb0475","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12954-016-0091-4","article-title":"Behavioral and quality-of-life outcomes in different service models for methadone maintenance treatment in Vietnam","volume":"13","author":"Tran","year":"2016","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2024.209383_bb0480","series-title":"Facing addiction in America: The surgeon General\u2019s spotlight on opiods","author":"U.S. Department of Health and Human Services, & Office of the Surgeon General","year":"2018"},{"key":"10.1016\/j.josat.2024.209383_bb0485","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2016.02.009","article-title":"Patients\u2019 beliefs about medications are associated with stated preference for methadone, buprenorphine, naltrexone, or no medication-assisted therapy following inpatient opioid detoxification","volume":"66","author":"Uebelacker","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209383_bb0490","author":"United States Census Bureau"},{"issue":"3","key":"10.1016\/j.josat.2024.209383_bb0495","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1037\/0022-0167.53.3.325","article-title":"Measuring the self-stigma associated with seeking psychological help","volume":"53","author":"Vogel","year":"2006","journal-title":"Journal of Counseling Psychology"},{"issue":"10118","key":"10.1016\/j.josat.2024.209383_bb0500","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(17)32893-3","article-title":"Medications for opioid use disorder: Bridging the gap in care","volume":"391","author":"Volkow","year":"2018","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.josat.2024.209383_bb0505","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies: Tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.josat.2024.209383_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMp1802741","article-title":"Primary care and the opioid-overdose crisis - buprenorphine myths and realities","volume":"379","author":"Wakeman","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.josat.2024.209383_bb0515","doi-asserted-by":"crossref","DOI":"10.1080\/08897077.2016.1187240","article-title":"Attitudes, practices, and preparedness to care for patients with substance use disorder: Results from a survey of general internists","author":"Wakeman","year":"2016","journal-title":"Substance Abuse"},{"issue":"1","key":"10.1016\/j.josat.2024.209383_bb0520","first-page":"33","article-title":"Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders","volume":"12","author":"Weaver","year":"2009","journal-title":"The Journal of Mental Health Policy and Economics"},{"issue":"1\u20132","key":"10.1016\/j.josat.2024.209383_bb0525","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2009.03.008","article-title":"Open-label dose-finding trial of buprenorphine implants (Probuphine)\u00ae for treatment of heroin dependence","volume":"103","author":"White","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"10","key":"10.1016\/j.josat.2024.209383_bb0530","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/10810730.2019.1669742","article-title":"Does discrimination breed mistrust? Examining the role of mediated and non-mediated discrimination experiences in medical mistrust","volume":"24","author":"Williamson","year":"2019","journal-title":"Journal of Health Communication"},{"key":"10.1016\/j.josat.2024.209383_bb0535","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.10.015","article-title":"Treatment utilization among persons with opioid use disorder in the United States","volume":"169","author":"Wu","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.josat.2024.209383_bb0540","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/1359105307088142","article-title":"Patient satisfaction and sustained outcomes of drug abuse treatment","volume":"13","author":"Zhiwei","year":"2008","journal-title":"Journal of Health Psychology"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294987592400095X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294987592400095X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T23:31:37Z","timestamp":1728603097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S294987592400095X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":107,"alternative-id":["S294987592400095X"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2024.209383","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating preferences for medication formulation and treatment model among people who use opioids non-medically: A web-based cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2024.209383","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209383"}}